Skip to content

Clinical trials

Phase 1 Parkinson Disease trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 1 Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20181
20193
20202
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexza Pharmaceuticals, Inc.2
Bial - Portela C S.A.1
Biogen1
H. Lundbeck A/S1
Hoffmann-La Roche1
Prevail Therapeutics1
Regeneron Pharmaceuticals1
UCB Biopharma SRL1
United Neuroscience Ltd.1
Vertero Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease11
Cognitive Dysfunction1
Mood Disorders1
Movement Disorders1
Muscle Rigidity1
Parasomnias1
Parkinsonian Disorders1
Primary Dysautonomias1
Tremor1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.